Urinary incontinence differential diagnosis: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(41 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Urinary incontinence}}
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Urinary_incontinence]]
{{CMG}}; {{AE}} {{SSH}}, {{HK}}
{{CMG}}; {{AE}} {{SSH}}, {{HK}}


Line 7: Line 7:


==Differential diagnosis of urinary incontinence==
==Differential diagnosis of urinary incontinence==
'''The following table differentiates the various types of urinary incontinence''':<ref name="urlpdfs.semanticscholar.org">{{cite web |url=https://pdfs.semanticscholar.org/0a01/f4ccaf0d943bd1d8d009b9d9ae6de1260511.pdf |title=pdfs.semanticscholar.org |format= |work= |accessdate=}}</ref><ref name="pmid16702587">{{cite journal |vauthors=Brown JS, Bradley CS, Subak LL, Richter HE, Kraus SR, Brubaker L, Lin F, Vittinghoff E, Grady D |title=The sensitivity and specificity of a simple test to distinguish between urge and stress urinary incontinence |journal=Ann. Intern. Med. |volume=144 |issue=10 |pages=715–23 |date=May 2006 |pmid=16702587 |pmc=1557357 |doi= |url=}}</ref><ref name="pmid18364487">{{cite journal |vauthors=Holroyd-Leduc JM, Tannenbaum C, Thorpe KE, Straus SE |title=What type of urinary incontinence does this woman have? |journal=JAMA |volume=299 |issue=12 |pages=1446–56 |date=March 2008 |pmid=18364487 |doi=10.1001/jama.299.12.1446 |url=}}</ref><ref name="pmid9611005">{{cite journal |vauthors=Videla FL, Wall LL |title=Stress incontinence diagnosed without multichannel urodynamic studies |journal=Obstet Gynecol |volume=91 |issue=6 |pages=965–8 |date=June 1998 |pmid=9611005 |doi= |url=}}</ref><ref name="pmid20025027">{{cite journal |vauthors=DuBeau CE, Kuchel GA, Johnson T, Palmer MH, Wagg A |title=Incontinence in the frail elderly: report from the 4th International Consultation on Incontinence |journal=Neurourol. Urodyn. |volume=29 |issue=1 |pages=165–78 |date=2010 |pmid=20025027 |doi=10.1002/nau.20842 |url=}}</ref><ref name="urlDiagnosis of Urinary Incontinence - American Family Physician">{{cite web |url=https://www.aafp.org/afp/2013/0415/p543.html#afp20130415p543-b6 |title=Diagnosis of Urinary Incontinence - American Family Physician |format= |work= |accessdate=}}</ref><ref name="pmid21075990">{{cite journal |vauthors=Frank C, Szlanta A |title=Office management of urinary incontinence among older patients |journal=Can Fam Physician |volume=56 |issue=11 |pages=1115–20 |date=November 2010 |pmid=21075990 |pmc=2980426 |doi= |url=}}</ref><ref name="pmid16985854">{{cite journal |vauthors=Imam KA |title=The role of the primary care physician in the management of bladder dysfunction |journal=Rev Urol |volume=6 Suppl 1 |issue= |pages=S38–44 |date=2004 |pmid=16985854 |pmc=1472846 |doi= |url=}}</ref>
'''''The following table differentiates the various types of urinary incontinence''':<ref name="urlpdfs.semanticscholar.org">{{cite web |url=https://pdfs.semanticscholar.org/0a01/f4ccaf0d943bd1d8d009b9d9ae6de1260511.pdf |title=pdfs.semanticscholar.org |format= |work= |accessdate=}}</ref><ref name="pmid16702587">{{cite journal |vauthors=Brown JS, Bradley CS, Subak LL, Richter HE, Kraus SR, Brubaker L, Lin F, Vittinghoff E, Grady D |title=The sensitivity and specificity of a simple test to distinguish between urge and stress urinary incontinence |journal=Ann. Intern. Med. |volume=144 |issue=10 |pages=715–23 |date=May 2006 |pmid=16702587 |pmc=1557357 |doi= |url=}}</ref><ref name="pmid18364487">{{cite journal |vauthors=Holroyd-Leduc JM, Tannenbaum C, Thorpe KE, Straus SE |title=What type of urinary incontinence does this woman have? |journal=JAMA |volume=299 |issue=12 |pages=1446–56 |date=March 2008 |pmid=18364487 |doi=10.1001/jama.299.12.1446 |url=}}</ref><ref name="pmid9611005">{{cite journal |vauthors=Videla FL, Wall LL |title=Stress incontinence diagnosed without multichannel urodynamic studies |journal=Obstet Gynecol |volume=91 |issue=6 |pages=965–8 |date=June 1998 |pmid=9611005 |doi= |url=}}</ref><ref name="pmid20025027">{{cite journal |vauthors=DuBeau CE, Kuchel GA, Johnson T, Palmer MH, Wagg A |title=Incontinence in the frail elderly: report from the 4th International Consultation on Incontinence |journal=Neurourol. Urodyn. |volume=29 |issue=1 |pages=165–78 |date=2010 |pmid=20025027 |doi=10.1002/nau.20842 |url=}}</ref><ref name="urlDiagnosis of Urinary Incontinence - American Family Physician">{{cite web |url=https://www.aafp.org/afp/2013/0415/p543.html#afp20130415p543-b6 |title=Diagnosis of Urinary Incontinence - American Family Physician |format= |work= |accessdate=}}</ref><ref name="pmid21075990">{{cite journal |vauthors=Frank C, Szlanta A |title=Office management of urinary incontinence among older patients |journal=Can Fam Physician |volume=56 |issue=11 |pages=1115–20 |date=November 2010 |pmid=21075990 |pmc=2980426 |doi= |url=}}</ref><ref name="pmid16985854">{{cite journal |vauthors=Imam KA |title=The role of the primary care physician in the management of bladder dysfunction |journal=Rev Urol |volume=6 Suppl 1 |issue= |pages=S38–44 |date=2004 |pmid=16985854 |pmc=1472846 |doi= |url=}}</ref>''


'''To review differential diagnosis of urge incontinence, click here.'''
'''''To review differential diagnosis of urge urinary incontinence, click [[Urge incontinence differential diagnosis|here]].'''''


'''To review differential diagnosis of stress incontinence, click here.'''
'''''To review differential diagnosis of stress urinary incontinence, click [[Stress incontinence differential diagnosis|here]].'''''


'''To review differential diagnosis of functional incontinence, click here.'''
'''''To review differential diagnosis of functional urinary incontinence, click [[Functional urinary incontinence differential diagnosis|here]].'''''


'''To review differential diagnosis of overflow incontinence, click here.'''
'''''To review differential diagnosis of overflow urinary incontinence, click [[Overflow urinary incontinence differential diagnosis|here]].'''''


'''To review differential diagnosis of mixed incontinence, click here.'''
'''''To review differential diagnosis of mixed urinary incontinence, click [[Mixed urinary incontinence differential diagnosis|here]].'''''
{|
{|
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
! rowspan="5" |Category
! rowspan="4" |Category
! rowspan="5" |Diseases
! rowspan="4" |Diseases
! colspan="4" rowspan="4" |Type of incontinence
! colspan="4" rowspan="3" |Type of incontinence
! colspan="10" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clinical manifestations
! colspan="9" rowspan="1" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clinical manifestations
! colspan="6" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para−clinical findings
! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings
! colspan="1" rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard
! colspan="1" rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
|-
|-
! colspan="7" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms
! colspan="7" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms
! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Signs
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Signs
|-
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab Findings
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
|-
|-
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Loss of consciousness
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Loss of consciousness
Line 38: Line 35:
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pelvic pain
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pelvic pain
! colspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Urinary symptoms
! colspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Urinary symptoms
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |BP
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Blood Pressure
! colspan="1" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Edema
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Neurological deficit
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Neurological deficit
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Urine residue
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Urine residue
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |UA
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |UA
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Ultrasound
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT scan
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
|-
|-
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Urge
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Urge
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Stress
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Stress
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Overflow
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Functional
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Functional
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Overflow
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dysuria
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dysuria
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Frequency
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Frequency
Line 61: Line 54:
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + |±
| align="center" style="background:#F5F5F5;" + |±
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + |−
Line 71: Line 64:
| align="center" style="background:#F5F5F5;" + | ++
| align="center" style="background:#F5F5F5;" + | ++
| align="center" style="background:#F5F5F5;" + |↑/↓
| align="center" style="background:#F5F5F5;" + |↑/↓
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |< 50 ml
| align="center" style="background:#F5F5F5;" + |< 50 ml
| align="center" style="background:#F5F5F5;" + |Pyuria
| align="center" style="background:#F5F5F5;" + |Pyuria ±
| align="center" style="background:#F5F5F5;" + |NA
| align="center" style="background:#F5F5F5;" + |NA
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |[[Imaging]]
| align="center" style="background:#F5F5F5;" + |[[Imaging]]
| align="left" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
* Associated with increased [[morbidity]] and [[Mortality rate|mortality]]
* Associated with increased [[morbidity]] and [[Mortality rate|mortality]]
* [[Depression]] 
* [[Depression]] 
* Might have pre-stroke [[urinary incontinence]]
* May have pre−stroke [[urinary incontinence]]
|-
|-
! align="center" style="background:#DCDCDC;" + |[[Alzheimer's disease]]<ref name="LeeLi2016">{{cite journal|last1=Lee|first1=Hsiang-Ying|last2=Li|first2=Ching-Chia|last3=Juan|first3=Yung-Shun|last4=Chang|first4=Yu-Han|last5=Yeh|first5=Hsin-Chih|last6=Tsai|first6=Chia-Chun|last7=Chueh|first7=Kuang-Shun|last8=Wu|first8=Wen-Jeng|last9=Yang|first9=Yuan-Han|title=Urinary Incontinence in Alzheimer’s Disease|journal=American Journal of Alzheimer's Disease & Other Dementiasr|volume=32|issue=1|year=2016|pages=51–55|issn=1533-3175|doi=10.1177/1533317516680900}}</ref>
! align="center" style="background:#DCDCDC;" + |[[Alzheimer's disease]]<ref name="LeeLi2016">{{cite journal|last1=Lee|first1=Hsiang-Ying|last2=Li|first2=Ching-Chia|last3=Juan|first3=Yung-Shun|last4=Chang|first4=Yu-Han|last5=Yeh|first5=Hsin-Chih|last6=Tsai|first6=Chia-Chun|last7=Chueh|first7=Kuang-Shun|last8=Wu|first8=Wen-Jeng|last9=Yang|first9=Yuan-Han|title=Urinary Incontinence in Alzheimer’s Disease|journal=American Journal of Alzheimer's Disease & Other Dementiasr|volume=32|issue=1|year=2016|pages=51–55|issn=1533-3175|doi=10.1177/1533317516680900}}</ref><ref name="DrennanRait2013">{{cite journal|last1=Drennan|first1=Vari M.|last2=Rait|first2=Greta|last3=Cole|first3=Laura|last4=Grant|first4=Robert|last5=Iliffe|first5=Steve|title=The prevalence of incontinence in people with cognitive impairment or dementia living at home: A systematic review|journal=Neurourology and Urodynamics|volume=32|issue=4|year=2013|pages=314–324|issn=07332467|doi=10.1002/nau.22333}}</ref>
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | -
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + | -
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |±
| align="center" style="background:#F5F5F5;" + |±
| align="center" style="background:#F5F5F5;" + |±
| align="center" style="background:#F5F5F5;" + |±
Line 98: Line 87:
| align="center" style="background:#F5F5F5;" + | ++
| align="center" style="background:#F5F5F5;" + | ++
| align="center" style="background:#F5F5F5;" + |Nl
| align="center" style="background:#F5F5F5;" + |Nl
| align="center" style="background:#F5F5F5;" + |-
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |+
| align="center" style="background:#F5F5F5;" + |< 50 ml
| align="center" style="background:#F5F5F5;" + |< 50 ml
| align="center" style="background:#F5F5F5;" + |Pyuria
| align="center" style="background:#F5F5F5;" + |Pyuria ±
| align="center" style="background:#F5F5F5;" + |NA
| align="center" style="background:#F5F5F5;" + |NA
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Clinical manifestations
| align="center" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
* [[Cognition|Cognitive]] impairment
| align="center" style="background:#F5F5F5;" + |
* [[Medication]] related
| align="center" style="background:#F5F5F5;" + |
* Cognitive impairment
* Increased risk of fall
* Medication related
|-
|-
! align="center" style="background:#DCDCDC;" + |[[Parkinson's disease]]
! align="center" style="background:#DCDCDC;" + |[[Parkinson's disease]]<ref name="LemackDewey2000">{{cite journal|last1=Lemack|first1=Gary E|last2=Dewey|first2=Richard B|last3=Roehrborn|first3=Claus G|last4=O’Suilleabhain|first4=Padraig E|last5=Zimmern|first5=Philippe E|title=Questionnaire-based assessment of bladder dysfunction in patients with mild to moderate Parkinson’s disease|journal=Urology|volume=56|issue=2|year=2000|pages=250–254|issn=00904295|doi=10.1016/S0090-4295(00)00641-5}}</ref><ref name="pmid17656188">{{cite journal |vauthors=Dubow JS |title=Autonomic dysfunction in Parkinson's disease |journal=Dis Mon |volume=53 |issue=5 |pages=265–74 |date=May 2007 |pmid=17656188 |doi=10.1016/j.disamonth.2007.02.004 |url=}}</ref>
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |±
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | ++
| align="center" style="background:#F5F5F5;" + | ++
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Nl to ↓
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |< 50 ml
| align="center" style="background:#F5F5F5;" + |< 50 ml
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Nl
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |NA
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Clinical manifestations
| align="center" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
*[[Fecal incontinence]]
| align="center" style="background:#F5F5F5;" + |
*[[Dysautonomia|Autonomic dysfunction]]
| align="center" style="background:#F5F5F5;" + |
*[[Orthostatic hypotension]]
*Side effects of medication
|-
|-
! align="center" style="background:#DCDCDC;" + |[[Altered mental status]]
! align="center" style="background:#DCDCDC;" + |[[Spinal cord injury|Traumatic spinal cord injury]]<ref name="SchurchStöhrer2000">{{cite journal|last1=Schurch|first1=B.|last2=Stöhrer|first2=M.|last3=Kramer|first3=G.|last4=Schmid|first4=D.M.|last5=Gaul|first5=G.|last6=Hauri|first6=D.|title=BOTULINUM-A TOXIN FOR TREATING DETRUSOR HYPERREFLEXIA IN SPINAL CORD INJURED PATIENTS: A NEW ALTERNATIVE TO ANTICHOLINERGIC DRUGS? PRELIMINARY RESULTS|journal=The Journal of Urology|volume=164|issue=3|year=2000|pages=692–697|issn=00225347|doi=10.1016/S0022-5347(05)67283-7}}</ref>
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |±
| align="center" style="background:#F5F5F5;" + |Nl to ↓
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |< 50 ml
| align="center" style="background:#F5F5F5;" + |< 50 ml
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Nl
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |NA
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |[[Magnetic resonance imaging|MRI]] of [[Spinal cord|spine]]
| align="center" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
*[[Paraplegia]]
| align="center" style="background:#F5F5F5;" + |
*[[Fecal incontinence]]
| align="center" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |[[Spinal cord injury|Traumatic spinal cord injury]]
! align="center" style="background:#DCDCDC;" + |[[Normal pressure hydrocephalus]]<ref name="GhoshLippa2014">{{cite journal|last1=Ghosh|first1=Sayantani|last2=Lippa|first2=Carol|title=Diagnosis and Prognosis in Idiopathic Normal Pressure Hydrocephalus|journal=American Journal of Alzheimer's Disease & Other Dementiasr|volume=29|issue=7|year=2014|pages=583–589|issn=1533-3175|doi=10.1177/1533317514523485}}</ref>
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Nl
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |±
| align="center" style="background:#F5F5F5;" + |> 200 ml
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Nl
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |NA
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |[[Cerebrospinal fluid]] ([[CSF]]) removal test
| align="center" style="background:#F5F5F5;" + |< 50 ml
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
* Slowly progressive gait abnormalities (Magnetic gait)
| align="center" style="background:#F5F5F5;" + |
* Cognitive deterioration (Dementia)
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |[[Multiple sclerosis]]
! align="center" style="background:#DCDCDC;" + |[[Multiple sclerosis]]<ref name="BoschGroen1996">{{cite journal|last1=Bosch|first1=JLH Ruud|last2=Groen|first2=Jan|title=Treatment of refractory urge urinary incontinence with sacral spinal nerve stimulation in multiple sclerosis patients|journal=The Lancet|volume=348|issue=9029|year=1996|pages=717–719|issn=01406736|doi=10.1016/S0140-6736(96)04437-6}}</ref>
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Nl to ↓
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |> 200 ml
| align="center" style="background:#F5F5F5;" + |> 200 ml
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Nl
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |NA
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |[[Magnetic resonance imaging|MRI]] of [[brain]] and [[Spinal cord|spine]]
| align="center" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
* [[Optic neuritis]] 
| align="center" style="background:#F5F5F5;" + |
* Sensory and motor abnormalities
| align="center" style="background:#F5F5F5;" + |
* Relapses and remission
|-
|-
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category
Line 212: Line 191:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Urge
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Urge
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Stress
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Stress
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Overflow
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Functional
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Functional
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Overflow
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Loss of consciousness
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Loss of consciousness
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdominal pain
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pelvic pain
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dysuria
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dysuria
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Frequency
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Frequency
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dribbling
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dribbling
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Nocturia
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Nocturia
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BP
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Blood Pressure
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Edema
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Neurological deficit
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Neurological deficit
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Urine residue
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Urine residue
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |UA
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |UA
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Ultrasound
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT scan
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings
|-
|-
! rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Urogenital disorders
! rowspan="7" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Urogenital disorders
! align="center" style="background:#DCDCDC;" + |[[Benign prostatic hyperplasia]]
! align="center" style="background:#DCDCDC;" + |[[Benign prostatic hyperplasia]]<ref name="PetersDonovan1997">{{cite journal|last1=Peters|first1=T.J.|last2=Donovan|first2=J.L.|last3=Kay|first3=H.E.|last4=Abrams|first4=P.|last5=de la Rosette|first5=J.J.M.C.H.|last6=Porru|first6=D.|last7=Thuroff|first7=J.W.|title=The International Continence Society “Benign Prostatic Hyperplasia” Study: The Bothersomeness of Urinary Symptoms|journal=The Journal of Urology|volume=157|issue=3|year=1997|pages=885–889|issn=00225347|doi=10.1016/S0022-5347(01)65075-4}}</ref>
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |±
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | ++
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |Nl to ↑
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |> 200 ml
| align="center" style="background:#F5F5F5;" + |> 200 ml
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |[[Hematuria]]
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Elevated [[Prostate specific antigen|PSA]] (less than 4 ng/dL)
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |[[Rectal examination|Digital rectal examination]]
| align="center" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
*Recurrent [[Urinary tract infection|urinary tract infections]]
| align="center" style="background:#F5F5F5;" + |
*[[Hydronephrosis]]
| align="center" style="background:#F5F5F5;" + |
*[[Renal insufficiency|Renal failure]]
|-
|-
! align="center" style="background:#DCDCDC;" + |[[Genitourinary system|Genitourinary]] [[surgical procedures]]
! align="center" style="background:#DCDCDC;" + |[[Genitourinary system|Genitourinary]] [[surgical procedures]]<ref name="AltmanGranath2007">{{cite journal|last1=Altman|first1=Daniel|last2=Granath|first2=Fredrik|last3=Cnattingius|first3=Sven|last4=Falconer|first4=Christian|title=Hysterectomy and risk of stress-urinary-incontinence surgery: nationwide cohort study|journal=The Lancet|volume=370|issue=9597|year=2007|pages=1494–1499|issn=01406736|doi=10.1016/S0140-6736(07)61635-3}}</ref><ref name="PrabhuSivarajan2014">{{cite journal|last1=Prabhu|first1=Vinay|last2=Sivarajan|first2=Ganesh|last3=Taksler|first3=Glen B.|last4=Laze|first4=Juliana|last5=Lepor|first5=Herbert|title=Long-term Continence Outcomes in Men Undergoing Radical Prostatectomy for Clinically Localized Prostate Cancer|journal=European Urology|volume=65|issue=1|year=2014|pages=52–57|issn=03022838|doi=10.1016/j.eururo.2013.08.006}}</ref>
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |±
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Depends on underlying disease
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |< 50 ml
| align="center" style="background:#F5F5F5;" + |< 50 ml
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Nl
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |NA
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Clinical manifestations
| align="center" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
*History of operation
| align="center" style="background:#F5F5F5;" + |
*History of pre−existing [[Urinary bladder|detrusor]] and/or [[sphincter]] dysfunction
| align="center" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |[[Childbirth|Multiple childbirths]]
! align="center" style="background:#DCDCDC;" + |[[Childbirth|Multiple childbirths]]<ref name="pmid29754281">{{cite journal |vauthors=Barbosa L, Boaviagem A, Moretti E, Lemos A |title=Multiparity, age and overweight/obesity as risk factors for urinary incontinence in pregnancy: a systematic review and meta-analysis |journal=Int Urogynecol J |volume= |issue= |pages= |date=May 2018 |pmid=29754281 |doi=10.1007/s00192-018-3656-9 |url=}}</ref><ref name="pmid23786421">{{cite journal |vauthors=Gyhagen M, Bullarbo M, Nielsen TF, Milsom I |title=A comparison of the long-term consequences of vaginal delivery versus caesarean section on the prevalence, severity and bothersomeness of urinary incontinence subtypes: a national cohort study in primiparous women |journal=BJOG |volume=120 |issue=12 |pages=1548–55 |date=November 2013 |pmid=23786421 |doi=10.1111/1471-0528.12367 |url=}}</ref>
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |±
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Nl
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |< 50 ml
| align="center" style="background:#F5F5F5;" + |< 50 ml
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Nl
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |NA
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Clinical manifestations
| align="center" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
*Increased risk in vaginal delivery
| align="center" style="background:#F5F5F5;" + |
*More common in [[Obesity|obese]] patients
| align="center" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |[[Uterine fibroids]]
! align="center" style="background:#DCDCDC;" + |[[Uterine fibroids]]<ref name="DragomirSchroeder2010">{{cite journal|last1=Dragomir|first1=Anca D.|last2=Schroeder|first2=Jane C.|last3=Connolly|first3=AnnaMarie|last4=Kupper|first4=Larry L.|last5=Cousins|first5=Deborah S.|last6=Olshan|first6=Andrew F.|last7=Baird|first7=Donna D.|title=Uterine Leiomyomata Associated with Self-Reported Stress Urinary Incontinence|journal=Journal of Women's Health|volume=19|issue=2|year=2010|pages=245–250|issn=1540-9996|doi=10.1089/jwh.2009.1396}}</ref>
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Nl
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |> 200 ml
| align="center" style="background:#F5F5F5;" + |> 200 ml
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Nl
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |NA
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Clinical manifestations+ imaging
| align="center" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
*[[Abnormal uterine bleeding]]
| align="center" style="background:#F5F5F5;" + |
*[[Constipation]]
| align="center" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |[[Uterine prolapse]]
! align="center" style="background:#DCDCDC;" + |[[Uterine prolapse]]<ref name="pmid20025017">{{cite journal |vauthors=de Boer TA, Salvatore S, Cardozo L, Chapple C, Kelleher C, van Kerrebroeck P, Kirby MG, Koelbl H, Espuna-Pons M, Milsom I, Tubaro A, Wagg A, Vierhout ME |title=Pelvic organ prolapse and overactive bladder |journal=Neurourol. Urodyn. |volume=29 |issue=1 |pages=30–9 |date=2010 |pmid=20025017 |doi=10.1002/nau.20858 |url=}}</ref>
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |±
| align="center" style="background:#F5F5F5;" + |Nl
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + |< 50 ml
| align="center" style="background:#F5F5F5;" + |Nl
| align="center" style="background:#F5F5F5;" + |NA
| align="center" style="background:#F5F5F5;" + |[[Pelvic examination]]
| align="left" style="background:#F5F5F5;" + |
*Increased risk in multiparity, advancing age, and [[obesity]]
*[[Constipation]]
*Fecal urgency
|-
! align="center" style="background:#DCDCDC;" + |[[Vesicovaginal fistula]]<ref name="pmid26001626">{{cite journal |vauthors=Reisenauer C |title=Vesicovaginal fistulas: a gynecological experience in 41 cases at a German pelvic floor center |journal=Arch. Gynecol. Obstet. |volume=292 |issue=2 |pages=245–53 |date=August 2015 |pmid=26001626 |doi=10.1007/s00404-015-3760-8 |url=}}</ref>
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |Nl
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + |< 50 ml
| align="center" style="background:#F5F5F5;" + |Nl
| align="center" style="background:#F5F5F5;" + |NA
| align="center" style="background:#F5F5F5;" + |[[Pelvic examination]]
| align="left" style="background:#F5F5F5;" + |
* History of [[Obstetrics|obstetric]], [[Pelvis|pelvic]], or [[Urology|urologic]] surgery
* History of prolonged or obstructed [[Childbirth|labor]]
|-
! align="center" style="background:#DCDCDC;" + |[[Bladder cancer]]<ref name="PorterPenson2005">{{cite journal|last1=Porter|first1=M|last2=Penson|first2=D|title=HEALTH RELATED QUALITY OF LIFE AFTER RADICAL CYSTECTOMY AND URINARY DIVERSION FOR BLADDER CANCER: A SYSTEMATIC REVIEW AND CRITICAL ANALYSIS OF THE LITERATURE|journal=The Journal of Urology|volume=173|issue=4|year=2005|pages=1318–1322|issn=00225347|doi=10.1097/01.ju.0000149080.82697.65}}</ref>
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + |±
| align="center" style="background:#F5F5F5;" + |±
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |< 50 ml
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Nl
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |> 200 ml
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |[[Hematuria]]
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |NA
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |[[Biopsy]]
| align="left" style="background:#F5F5F5;" + |
* [[Smoking|Cigarette smoking]]
* History of occupational exposure
* History of travel to  endemic areas of ''[[Schistosoma haematobium]]''
|-
|-
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gastrointestinal diseases
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gastrointestinal diseases
! align="center" style="background:#DCDCDC;" + |[[Fecal impaction]]
! align="center" style="background:#DCDCDC;" + |[[Fecal impaction]]<ref name="Loening-Baucke1997">{{cite journal|last1=Loening-Baucke|first1=V.|title=Urinary Incontinence and Urinary Tract Infection and Their Resolution With Treatment of Chronic Constipation of Childhood|journal=PEDIATRICS|volume=100|issue=2|year=1997|pages=228–232|issn=0031-4005|doi=10.1542/peds.100.2.228}}</ref>
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Nl
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |> 200 ml
| align="center" style="background:#F5F5F5;" + |> 200 ml
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Pyuria
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |↑ K<sup>+</sup>
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |[[Rectal examination|Digital rectal examination]]
| align="center" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
*[[Lower gastrointestinal bleeding]]
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
|-
|-
! align="center" style="background:#DCDCDC;" + |[[Rectal prolapse]]
! align="center" style="background:#DCDCDC;" + |[[Rectal prolapse]]<ref name="González-ArgentéJain2001">{{cite journal|last1=González-Argenté|first1=Xavier F.|last2=Jain|first2=Anil|last3=Nogueras|first3=Juan J.|last4=Davila|first4=Willy G.|last5=Weiss|first5=Eric G.|last6=Wexner|first6=Steven D.|title=Prevalence and severity of urinary incontinence and pelvic genital prolapse in females with anal incontinence or rectal prolapse|journal=Diseases of the Colon & Rectum|volume=44|issue=7|year=2001|pages=920–925|issn=0012-3706|doi=10.1007/BF02235476}}</ref>
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + |−
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | −
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + | +
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Nl
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |> 200 ml
| align="center" style="background:#F5F5F5;" + |> 200 ml
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |Pyuria
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |NA
| align="center" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |[[Pelvic examination]]
| align="center" style="background:#F5F5F5;" + |
| align="left" style="background:#F5F5F5;" + |
| align="center" style="background:#F5F5F5;" + |
*[[Fecal incontinence]]
| align="center" style="background:#F5F5F5;" + |
*[[Constipation]]
| align="center" style="background:#F5F5F5;" + |
|-
|-
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category
Line 407: Line 414:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Urge
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Urge
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Stress
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Stress
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Overflow
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Functional
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Functional
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Overflow
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Loss of consciousness
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Loss of consciousness
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Fever
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Abdominal pain
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pelvic pain
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dysuria
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dysuria
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Frequency
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Frequency
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dribbling
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dribbling
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Nocturia
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Nocturia
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |BP
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Blood Pressure
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Edema
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Neurological deficit
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Neurological deficit
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Urine residue
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Urine residue
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |UA
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |UA
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Ultrasound
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT scan
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard
Line 432: Line 435:
{{Reflist|2}}
{{Reflist|2}}


[[Category:Medicine]]
[[Category:Urology]]
[[Category:Urology]]
[[Category:Needs content]]
[[Category:Nephrology]]
[[Category:Primary care]]
[[Category:Up-To-Date]]
 
{{WH}}
{{WS}}

Latest revision as of 00:36, 30 July 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2], Syed Hassan A. Kazmi BSc, MD [3]

Overview

Urinary incontinence may have different etiologies depending upon the underlying dysfunction. The various types of urinary incontinence should be differentiated from each other for optimal management.

Differential diagnosis of urinary incontinence

The following table differentiates the various types of urinary incontinence:[1][2][3][4][5][6][7][8]

To review differential diagnosis of urge urinary incontinence, click here.

To review differential diagnosis of stress urinary incontinence, click here.

To review differential diagnosis of functional urinary incontinence, click here.

To review differential diagnosis of overflow urinary incontinence, click here.

To review differential diagnosis of mixed urinary incontinence, click here.

Category Diseases Type of incontinence Clinical manifestations Lab Findings Gold standard Associated findings
Symptoms Signs
Loss of consciousness Fever Pelvic pain Urinary symptoms Blood Pressure Neurological deficit Urine residue UA Other
Urge Stress Overflow Functional Dysuria Frequency Dribbling Nocturia
Neurological diseases Stroke[9] + + ± + ± + + ++ ↑/↓ + < 50 ml Pyuria ± NA Imaging
Alzheimer's disease[10][11] + + + + ± ± + + ++ Nl + < 50 ml Pyuria ± NA Clinical manifestations
Parkinson's disease[12][13] + ± + + ++ Nl to ↓ + < 50 ml Nl NA Clinical manifestations
Traumatic spinal cord injury[14] + + + ± Nl to ↓ + < 50 ml Nl NA MRI of spine
Normal pressure hydrocephalus[15] + + + Nl + > 200 ml Nl NA Cerebrospinal fluid (CSF) removal test
  • Slowly progressive gait abnormalities (Magnetic gait)
  • Cognitive deterioration (Dementia)
Multiple sclerosis[16] + + + + + Nl to ↓ + > 200 ml Nl NA MRI of brain and spine
  • Optic neuritis 
  • Sensory and motor abnormalities
  • Relapses and remission
Category Diseases Urge Stress Overflow Functional Loss of consciousness Fever Pelvic pain Dysuria Frequency Dribbling Nocturia Blood Pressure Neurological deficit Urine residue UA Other Gold standard Additional findings
Urogenital disorders Benign prostatic hyperplasia[17] + + + + ± + ++ + Nl to ↑ > 200 ml Hematuria Elevated PSA (less than 4 ng/dL) Digital rectal examination
Genitourinary surgical procedures[18][19] + + ± + + + + Depends on underlying disease < 50 ml Nl NA Clinical manifestations
Multiple childbirths[20][21] + + ± + + + Nl < 50 ml Nl NA Clinical manifestations
  • Increased risk in vaginal delivery
  • More common in obese patients
Uterine fibroids[22] + + + + + Nl > 200 ml Nl NA Clinical manifestations+ imaging
Uterine prolapse[23] + + + + + ± Nl < 50 ml Nl NA Pelvic examination
Vesicovaginal fistula[24] + + + + + Nl < 50 ml Nl NA Pelvic examination
Bladder cancer[25] + + ± + + + + Nl > 200 ml Hematuria NA Biopsy
Gastrointestinal diseases Fecal impaction[26] + + + + + Nl > 200 ml Pyuria ↑ K+ Digital rectal examination
Rectal prolapse[27] + + + + Nl > 200 ml Pyuria NA Pelvic examination
Category Diseases Urge Stress Overflow Functional Loss of consciousness Fever Pelvic pain Dysuria Frequency Dribbling Nocturia Blood Pressure Neurological deficit Urine residue UA Other Gold standard Additional findings

References

  1. "pdfs.semanticscholar.org" (PDF).
  2. Brown JS, Bradley CS, Subak LL, Richter HE, Kraus SR, Brubaker L, Lin F, Vittinghoff E, Grady D (May 2006). "The sensitivity and specificity of a simple test to distinguish between urge and stress urinary incontinence". Ann. Intern. Med. 144 (10): 715–23. PMC 1557357. PMID 16702587.
  3. Holroyd-Leduc JM, Tannenbaum C, Thorpe KE, Straus SE (March 2008). "What type of urinary incontinence does this woman have?". JAMA. 299 (12): 1446–56. doi:10.1001/jama.299.12.1446. PMID 18364487.
  4. Videla FL, Wall LL (June 1998). "Stress incontinence diagnosed without multichannel urodynamic studies". Obstet Gynecol. 91 (6): 965–8. PMID 9611005.
  5. DuBeau CE, Kuchel GA, Johnson T, Palmer MH, Wagg A (2010). "Incontinence in the frail elderly: report from the 4th International Consultation on Incontinence". Neurourol. Urodyn. 29 (1): 165–78. doi:10.1002/nau.20842. PMID 20025027.
  6. "Diagnosis of Urinary Incontinence - American Family Physician".
  7. Frank C, Szlanta A (November 2010). "Office management of urinary incontinence among older patients". Can Fam Physician. 56 (11): 1115–20. PMC 2980426. PMID 21075990.
  8. Imam KA (2004). "The role of the primary care physician in the management of bladder dysfunction". Rev Urol. 6 Suppl 1: S38–44. PMC 1472846. PMID 16985854.
  9. Gibson J, Thomas LH, Harrison JJ, Watkins CL (March 2018). "Stroke survivors' and carers' experiences of a systematic voiding programme to treat urinary incontinence after stroke". J Clin Nurs. doi:10.1111/jocn.14346. PMID 29517816. Vancouver style error: initials (help)
  10. Lee, Hsiang-Ying; Li, Ching-Chia; Juan, Yung-Shun; Chang, Yu-Han; Yeh, Hsin-Chih; Tsai, Chia-Chun; Chueh, Kuang-Shun; Wu, Wen-Jeng; Yang, Yuan-Han (2016). "Urinary Incontinence in Alzheimer's Disease". American Journal of Alzheimer's Disease & Other Dementiasr. 32 (1): 51–55. doi:10.1177/1533317516680900. ISSN 1533-3175.
  11. Drennan, Vari M.; Rait, Greta; Cole, Laura; Grant, Robert; Iliffe, Steve (2013). "The prevalence of incontinence in people with cognitive impairment or dementia living at home: A systematic review". Neurourology and Urodynamics. 32 (4): 314–324. doi:10.1002/nau.22333. ISSN 0733-2467.
  12. Lemack, Gary E; Dewey, Richard B; Roehrborn, Claus G; O’Suilleabhain, Padraig E; Zimmern, Philippe E (2000). "Questionnaire-based assessment of bladder dysfunction in patients with mild to moderate Parkinson's disease". Urology. 56 (2): 250–254. doi:10.1016/S0090-4295(00)00641-5. ISSN 0090-4295.
  13. Dubow JS (May 2007). "Autonomic dysfunction in Parkinson's disease". Dis Mon. 53 (5): 265–74. doi:10.1016/j.disamonth.2007.02.004. PMID 17656188.
  14. Schurch, B.; Stöhrer, M.; Kramer, G.; Schmid, D.M.; Gaul, G.; Hauri, D. (2000). "BOTULINUM-A TOXIN FOR TREATING DETRUSOR HYPERREFLEXIA IN SPINAL CORD INJURED PATIENTS: A NEW ALTERNATIVE TO ANTICHOLINERGIC DRUGS? PRELIMINARY RESULTS". The Journal of Urology. 164 (3): 692–697. doi:10.1016/S0022-5347(05)67283-7. ISSN 0022-5347.
  15. Ghosh, Sayantani; Lippa, Carol (2014). "Diagnosis and Prognosis in Idiopathic Normal Pressure Hydrocephalus". American Journal of Alzheimer's Disease & Other Dementiasr. 29 (7): 583–589. doi:10.1177/1533317514523485. ISSN 1533-3175.
  16. Bosch, JLH Ruud; Groen, Jan (1996). "Treatment of refractory urge urinary incontinence with sacral spinal nerve stimulation in multiple sclerosis patients". The Lancet. 348 (9029): 717–719. doi:10.1016/S0140-6736(96)04437-6. ISSN 0140-6736.
  17. Peters, T.J.; Donovan, J.L.; Kay, H.E.; Abrams, P.; de la Rosette, J.J.M.C.H.; Porru, D.; Thuroff, J.W. (1997). "The International Continence Society "Benign Prostatic Hyperplasia" Study: The Bothersomeness of Urinary Symptoms". The Journal of Urology. 157 (3): 885–889. doi:10.1016/S0022-5347(01)65075-4. ISSN 0022-5347.
  18. Altman, Daniel; Granath, Fredrik; Cnattingius, Sven; Falconer, Christian (2007). "Hysterectomy and risk of stress-urinary-incontinence surgery: nationwide cohort study". The Lancet. 370 (9597): 1494–1499. doi:10.1016/S0140-6736(07)61635-3. ISSN 0140-6736.
  19. Prabhu, Vinay; Sivarajan, Ganesh; Taksler, Glen B.; Laze, Juliana; Lepor, Herbert (2014). "Long-term Continence Outcomes in Men Undergoing Radical Prostatectomy for Clinically Localized Prostate Cancer". European Urology. 65 (1): 52–57. doi:10.1016/j.eururo.2013.08.006. ISSN 0302-2838.
  20. Barbosa L, Boaviagem A, Moretti E, Lemos A (May 2018). "Multiparity, age and overweight/obesity as risk factors for urinary incontinence in pregnancy: a systematic review and meta-analysis". Int Urogynecol J. doi:10.1007/s00192-018-3656-9. PMID 29754281.
  21. Gyhagen M, Bullarbo M, Nielsen TF, Milsom I (November 2013). "A comparison of the long-term consequences of vaginal delivery versus caesarean section on the prevalence, severity and bothersomeness of urinary incontinence subtypes: a national cohort study in primiparous women". BJOG. 120 (12): 1548–55. doi:10.1111/1471-0528.12367. PMID 23786421.
  22. Dragomir, Anca D.; Schroeder, Jane C.; Connolly, AnnaMarie; Kupper, Larry L.; Cousins, Deborah S.; Olshan, Andrew F.; Baird, Donna D. (2010). "Uterine Leiomyomata Associated with Self-Reported Stress Urinary Incontinence". Journal of Women's Health. 19 (2): 245–250. doi:10.1089/jwh.2009.1396. ISSN 1540-9996.
  23. de Boer TA, Salvatore S, Cardozo L, Chapple C, Kelleher C, van Kerrebroeck P, Kirby MG, Koelbl H, Espuna-Pons M, Milsom I, Tubaro A, Wagg A, Vierhout ME (2010). "Pelvic organ prolapse and overactive bladder". Neurourol. Urodyn. 29 (1): 30–9. doi:10.1002/nau.20858. PMID 20025017.
  24. Reisenauer C (August 2015). "Vesicovaginal fistulas: a gynecological experience in 41 cases at a German pelvic floor center". Arch. Gynecol. Obstet. 292 (2): 245–53. doi:10.1007/s00404-015-3760-8. PMID 26001626.
  25. Porter, M; Penson, D (2005). "HEALTH RELATED QUALITY OF LIFE AFTER RADICAL CYSTECTOMY AND URINARY DIVERSION FOR BLADDER CANCER: A SYSTEMATIC REVIEW AND CRITICAL ANALYSIS OF THE LITERATURE". The Journal of Urology. 173 (4): 1318–1322. doi:10.1097/01.ju.0000149080.82697.65. ISSN 0022-5347.
  26. Loening-Baucke, V. (1997). "Urinary Incontinence and Urinary Tract Infection and Their Resolution With Treatment of Chronic Constipation of Childhood". PEDIATRICS. 100 (2): 228–232. doi:10.1542/peds.100.2.228. ISSN 0031-4005.
  27. González-Argenté, Xavier F.; Jain, Anil; Nogueras, Juan J.; Davila, Willy G.; Weiss, Eric G.; Wexner, Steven D. (2001). "Prevalence and severity of urinary incontinence and pelvic genital prolapse in females with anal incontinence or rectal prolapse". Diseases of the Colon & Rectum. 44 (7): 920–925. doi:10.1007/BF02235476. ISSN 0012-3706.